Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond.

Simona LattanziValentina ChiesaGiancarlo Di GennaroEdoardo FerlazzoAngelo LabateAngela La NeveStefano MelettiCarlo Di Bonaventuranull null

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)

These characteristics also make it suitable as an early add-on for the elderly and for patients with post-stroke epilepsy or status epilepticus as highlighted by the present Delphi consensus.

Keyphrases

clinical practice
middle aged
temporal lobe epilepsy
community dwelling
stem cells
mesenchymal stem cells
cell therapy
replacement therapy